Search Results 631-640 of 19277 for Hemoglobin

1. Aortic Valve Repair And Aortic Valve Replacement Clinical Trials - Mayo Clinic Research

   The purpose of this study is to test if a reduction of hemoglobin leads to subclinical cardiac dysfunction in patients with known cardiovascular disease. .

2. A Study to Evaluate Injectafer® as Treatment for Heart Failure with Iron Deficiency - Mayo Clinic

   Hemoglobin > 9.0 g/dL and < 13.5 g/dL (females) or < 15.0 g/dL (males) within 28 days of randomization. Serum ferritin < 100 ng/mL or 100 to 300 ng/mL with ...

3. Home Care Treatment With Oral Chemotherapy For Recurrent Or Metastatic Oral Cavity Cancer - Mayo Clinic

   Hemoglobin ≥9.0 g/dL. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ≥100,000/mm3. Total bilirubin ≤1.5 x ULN. Alanine aminotransferase (ALT) and ...

4. A Study To Evaluate Intravenous Iloprost In Subjects With Symptomatic Raynaud's Phenomenon Secondary To Systemic Sclerosis - Mayo Clinic

   ... hemoglobin). Subjects with scleroderma renal crisis within 6 months of screening. Subjects with a concomitant life-threatening disease with a life ...

5. Belimumab With Rituximab for Primary Membranous Nephropathy (REBOOT) - Mayo Clinic

   Moderately severe anemia (hemoglobin \< 9 g/dL) 17. History of primary immunodeficiency 18. Serum IgA \< 10 mg/dL 19. Alanine aminotransferase (ALT) or ...

6. A Study to Establish a Biobank of Blood Samples to Study the Relationship Between Diabetes Mellitus and Other Pancreatic Conditions - Mayo Clinic

   Hemoglobin A1c (HbA1c) ≥ 6.5%; Random Blood Glucose (RBG) ≥200 mg/dl; 2h Post Glucose (PG) ≥200mg (11.1 mmol/L) during OGTT (oral glucose tolerance test).

7. Combination Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma - Mayo Clinic

   Hemoglobin > 8 g/dL (RBC transfusions allowed); Prior corticosteroids allowed; No prior radiation therapy or chemotherapy. Participating Mayo Clinic locations.

8. Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study - Mayo Clinic

   Hemoglobin (Hgb) < 9 g/dl; Renal replacement therapy; History of renal artery stenosis > 50%; Hemodynamically significant arrhythmias including ventricular ...

9. Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection - Mayo Clinic

   Uncontrolled diabetes, defined as hemoglobin A1c > 7.4%. BMI > 45; Any acute illness within 14 days of Day 1 that could confound the evaluation of safety ...

10. CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study - Mayo Clinic

    Hemoglobin < 8.5 gm/dl; Other acute or chronic medical conditions or laboratory abnormality which may increase the risks associated with study participation ...